Tuscaloosa, ALNCT06445946Now EnrollingIRB Ready

Gestational Diabetes Clinical Trial in Tuscaloosa, AL

Access cutting-edge gestational diabetes treatment through this clinical trial at a research site in Tuscaloosa. Study-provided care at no cost to qualified participants.

Sponsored by Ohio State University

Quick Self-Assessment

See if you qualify for this Tuscaloosa location

Preparing your pre-screening questions...

Expert Care in Tuscaloosa

Access gestational diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related gestational diabetes treatment provided free

Apply for This Tuscaloosa Location

Check if you qualify for this gestational diabetes clinical trial in Tuscaloosa, AL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tuscaloosa

    Convenient for AL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tuscaloosa site if eligible
  4. 4Begin participation

About This Gestational Diabetes Study in Tuscaloosa

This is a non-inferiority patient-centered and pragmatic comparative-effectiveness pregnancy randomized controlled trial (RCT) with postpartum maternal and child follow-up through 2 years of 1,572 individuals with gestational diabetes mellitus (GDM) randomized to oral metformin versus injectable insulin. This study will determine if metformin is not inferior to insulin in reducing adverse pregnancy outcomes, is comparably safe for exposed individuals and children, and if patient-reported factor

Sponsor: Ohio State University

Who Can Participate

Inclusion Criteria

Singleton gestation. Twin reduction to singleton, either spontaneously or therapeutically, is eligible if it occurred before 14 weeks gestational age.
Age 18 years or older
Gestational age at randomization between 20 0/7 - 32 6/7 weeks based on project gestational age.
GDM diagnosis less than or equal to 31 6/7 weeks based on project gestational age.
Requires medication for glucose control defined as ≥ 30% elevated glucose values (either fasting or postprandial or both) prior to randomization per determination of the provider or documented in the medical record.
Patient willingness and ability to attend 2-year follow-up visit.

Exclusion Criteria

Renal disease (serum creatinine \>1.3 mg/dL) due to the potential impact of metformin on renal function.
Major structural malformation of the fetus.
Known fetal aneuploidy based on invasive testing or positive for aneuploidy on cell-free fetal DNA screening.
Contraindication to metformin or insulin, i

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tuscaloosa?

Yes, this clinical trial (NCT06445946) has an active research site in Tuscaloosa, AL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Gestational Diabetes Treatment Options in Tuscaloosa, AL

If you're searching for gestational diabetes treatment options in Tuscaloosa, AL, this clinical trial (NCT06445946) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tuscaloosa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gestational diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all gestational diabetes clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Tuscaloosa, AL

See all essential tremor clinical trials recruiting in Tuscaloosa — not just this study.

Browse Essential Tremor Trials in Tuscaloosa

Ready to Join in Tuscaloosa?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tuscaloosa, AL